Company Earnings Update 3 minutesRegister for Free AccessWalgreens Boots Alliance (NYSE: WBA) 2Q19 Results: Pricing and Reimbursement Pressures Hit Earnings; Company Lowers FY19 EPS Guidance Coresight Research April 3, 2019 Executive Summary Walgreens Boots Alliance reported 2Q19 revenues of $34.5 billion, in line with the consensus estimate and up 4.6% year over year. Diluted EPS came in at $1.24, down 8.8% year over year and below the consensus estimate of $1.50. Comps for the Retail Pharmacy USA business fell 3.8%, while Retail Pharmacy International comps decreased 1.4%. For FY19, Walgreens expects flat adjusted EPS, revised down from 7–12% growth. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: Essentials In-Store, Discretionary Online: China Consumer Survey InsightsWeekly US and UK Store Openings and Closures Tracker 2023, Week 45: Amazon Completes Its Brick-and-Mortar Retreat to GroceryGroceryshop 2023 Day Three: Opportunities in Grocery in 2023 and BeyondWeb3 and the Supply Chain: Blockchain, Digital Twins and More—Insights Presented at Shoptalk 2023
